In vitro and in vivo production and purification of circular RNA aptamer

Journal of Biotechnology

Volumn 139, Issue 4, 2009, Pages 265-272

  Umekage, So ^a   Kikuchi, Yo ^a  

^a TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Circular RNA aptamer; In vivo expression; Self splicing; Solid phase DNA probe method

Indexed keywords

ALTERNATIVE METHODS; ANION-EXCHANGE CHROMATOGRAPHIES; APTAMER; APTAMERS; CELL EXTRACTS; CIRCULAR RNA APTAMER; E. COLI; ESCHERICHIA COLI CELLS; EXON SEQUENCES; GEL ELECTROPHORESIS; HELA CELLS; IN VIVO EXPRESSION; IN-VITRO; RNA MOLECULES; RNA THERAPEUTICS; SELF-SPLICING; SOLID-PHASE DNA PROBE METHOD; STREPTAVIDIN;

CHEMICAL MODIFICATION; CHROMATOGRAPHIC ANALYSIS; DNA; ELECTROPHORESIS; ESCHERICHIA COLI; GELATION; GENES; MEDICAL APPLICATIONS; PROBES; PURIFICATION; RNA;

NUCLEIC ACIDS;

APTAMER; RNA; STREPTAVIDIN;

ARTICLE; BACTERIOPHAGE T4; CONTROLLED STUDY; ESCHERICHIA COLI; EXON; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; NONHUMAN; PRIORITY JOURNAL; RNA PURIFICATION; RNA SEQUENCE; RNA SPLICING; RNA SYNTHESIS;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CLONING, MOLECULAR; DRUG STABILITY; ESCHERICHIA COLI; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RNA; RNA, BACTERIAL; SERUM; STREPTAVIDIN;

ESCHERICHIA COLI;

EID: 60549105176     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2008.12.012     Document Type: Article

References (34)

1. Beaudry D., and Perreault J.P. An efficient strategy for the synthesis of circular RNA molecules. Nucleic Acids Res. 23 (1995) 3064-3066
2. Bohjanen P.R., Liu Y., and Garcia-Blanco M.A. TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res. 25 (1997) 4481-4486
3. Bohjanen P.R., Colvin R.A., Puttaraju M., Been M.D., and Garcia-Blanco M.A. A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription. Nucleic Acids Res. 24 (1996) 3733-3738
4. Burmeister P.E., Lewis S.D., Silva R.F., Preiss J.R., Horwitz L.R., Pendergrast P.S., McCauley T.G., Kurz J.C., Epstein D.M., Wilson C., and Keefe A.D. Direct in vitro selection of a 2′-O-methyl aptamer to VEGF. Chem. Biol. 12 (2005) 25-33
5. Chen C.Y., and Sarnow P. Internal ribosome entry sites tests with circular mRNAs. Methods Mol. Biol. 77 (1998) 355-363
6. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
7. Chung C.T., Niemela S.L., and Miller R.H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 2172-2175
8. Di Primo C., Rudloff I., Reigadas S., Arzumanov A.A., Gait M.J., and Toulme J.J. Systematic screening of LNA/2′-O-methyl chimeric derivatives of a TAR RNA aptamer. FEBS Lett. 581 (2007) 771-774
9. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
10. Feldstein P.A., Levy L., Randles J.W., and Owens R.A. Synthesis and two-dimensional electrophoretic analysis of mixed populations of circular and linear RNAs. Nucleic Acids Res. 25 (1997) 4850-4854
11. Ford E., and Ares Jr. M. Synthesis of circular RNA in bacteria and yeast using RNA cyclase ribozymes derived from a group I intron of phage T4. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3117-3121
12. Frazão C., McVey C.E., Amblar M., Barbas A., Vonrhein C., Arraiano C.M., and Carrondo M.A. Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex. Nature 443 (2006) 110-114
13. Haupenthal J., Baehr C., Kiermayer S., Zeuzem S., and Piiper A. Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem. Pharmacol. 71 (2006) 702-710
14. Haupenthal J., Baehr C., Zeuzem S., and Piiper A. RNase A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1. Int. J. Cancer 121 (2007) 206-210
15. Kang J., Lee M.S., Watowich S.J., and Gorenstein D.G. Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein. FEBS Lett. 581 (2007) 2497-2502
16. Kim I., McKenna S.A., Puglisi V.E., and Puglisi J.D. Rapid purification of RNAs using fast performance liquid chromatography (FPLC). RNA 13 (2007) 289-294
17. Konig J., Julius C., Baumann S., Homann M., Goringer H.U., and Feldbrugge M. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers. RNA 13 (2007) 614-622
18. Lee J.H., Canny M.D., De Erkenez A., Krilleke D., Ng Y.S., Shima D.T., Pardi A., and Jucker F. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18902-18907
19. Lukavsky P.J., and Puglisi J.D. Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides. RNA 10 (2004) 889-893
20. Mi J., Zhang X., Rabbani Z.N., Liu Y., Su Z., Vujaskovic Z., Kontos C.D., Bruce A., Sullenger B.A., and Clary B.M. H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res. 34 (2006) 3577-3584
21. Perriman R., and Ares Jr. M. Circular mRNA can direct translation of extremely long repeating-sequence proteins in vivo. RNA 4 (1998) 1047-1054
22. Pieken W.A., Olsen D.B., Benseler F., Aurup H., and Eckstein F. Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253 (1991) 314-317
23. Ponchon L., and Dardel F. Recombinant RNA technology: the tRNA scaffold. Nat. Methods 4 (2007) 571-576
24. Puttaraju M., and Been M.D. Group I permuted intron-exon (PIE) sequences self-splice to produce circular exons. Nucleic Acids Res. 20 (1992) 5357-5364
25. Puttaraju M., Perrotta A.T., and Been M.D. A circular trans-acting hepatitis delta virus ribozyme. Nucleic Acids Res. 21 (1993) 4253-4258
26. Puttaraju M., and Been M.D. Circular ribozymes generated in Escherichia coli using group I self-splicing permuted intron-exon sequences. J. Biol. Chem. 271 (1996) 26081-26087
27. Schmidt K.S., Borkowski S., Kurreck J., Stephens A.W., Bald R., Hecht M., Friebe M., Dinkelborg L., and Erdmann V.A. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res. 32 (2004) 5757-5765
28. Schumacher J., Randles J.W., and Riesner D. A two-dimensional electrophoretic technique for the detection of circular viroids and virosoids. Anal. Biochem. 135 (1983) 288-295
29. Sioud M., and Sorensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312 (2003) 1220-1225
30. Sorensen D.R., Leirdal M., and Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327 (2003) 761-766
31. Srisawat C., and Engelke Q.R. Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. RNA 7 (2001) 632-641
32. Suzuki T., Suzuki T., Wada T., Saigo K., and Watanabe K. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21 (2002) 6581-6589
33. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
34. Turner J.J., Jones S.W., Moschos S.A., Lindsay M.A., and Gait M.J. MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNase A-like activity. Mol. BioSystems 3 (2007) 43-50